|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Oncology (J.Z., T.T., F.V., and C.E.C.) and Physiology (K.M.S., E.K., and J.D.Y.), Membrane Protein Research Group (J.Z., K.M.S., T.T., F.V., J.D.Y. and C.E.C.), University of Alberta, and the Cross Cancer Institute (J.Z., T.T., F.V. and C.E.C.), Edmonton, Alberta, Canada; the Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah (M.J.R., L.P.C.N., and I.N.); and the School of Biochemistry and Molecular Biology, University of Leeds, Leeds, United Kingdom (S.A.B.)
Human concentrative nucleoside transporters 1, 2, and 3 (hCNT1, hCNT2, and hCNT3) exhibit different functional characteristics, and a better understanding of their permeant selectivities is critical for development of nucleoside analog drugs with optimal pharmacokinetic properties. In this study, the sensitivity of a high-throughput yeast expression system used previously for hCNT1 and hCNT3 was improved and used to characterize determinants for interaction of uridine (Urd) with hCNT2. The observed changes of binding energy between hCNT2 and different Urd analogs suggested that it interacts with C(3')-OH, C(5')-OH, and N(3)-H of Urd. The C(2') and C(5) regions of Urd played minor but significant roles for Urd-hCNT2 binding, possibly through Van der Waals interactions. Because the yeast assay only provided information about potential transportability, the permeant selectivities of recombinant hCNT1, hCNT2, and hCNT3 produced in Xenopus laevis oocytes were investigated using a two-electrode voltage clamp assay. hCNT1-mediated transport was sensitive to modifications of the N(3), C(3'), and C(5') positions of Urd. hCNT2 showed some tolerance for transporting Urd analogs with C(2') or C(5) modifications, little tolerance for N(3) modifications, and no tolerance for any modifications at C(3') or C(5') of Urd. Although hCNT3 was sensitive to C(3') modifications, it transported a broad range of variously substituted Urd analogs. The transportability profiles identified in this study, which reflected the binding profiles well, should prove useful in the development of anticancer and antiviral therapies with nucleoside drugs that are permeants of members of the hCNT protein family.
Address correspondence to: Dr. Carol E. Cass, Department of Oncology, University of Alberta, Cross Cancer Institute, 11540 University Ave., Edmonton, Alberta, Canada T6H 1Z2. E-mail: carol.cass{at}cancerboard.ab.ca
This article has been cited by other articles:
![]() |
A. N. Elwi, V. L. Damaraju, M. L. Kuzma, D. A. Mowles, S. A. Baldwin, J. D. Young, M. B. Sawyer, and C. E. Cass Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3 Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1439 - F1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Paproski, A. M. L. Ng, S. Y. M. Yao, K. Graham, J. D. Young, and C. E. Cass The Role of Human Nucleoside Transporters in Uptake of 3'-Deoxy-3'-fluorothymidine Mol. Pharmacol., November 1, 2008; 74(5): 1372 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Damaraju, A. N. Elwi, C. Hunter, P. Carpenter, C. Santos, G. M. Barron, X. Sun, S. A. Baldwin, J. D. Young, J. R. Mackey, et al. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney Am J Physiol Renal Physiol, July 1, 2007; 293(1): F200 - F211. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Larrayoz, A. Fernandez-Nistal, A. Garces, E. Gorraitz, and M. P. Lostao Characterization of the rat Na+/nucleoside cotransporter 2 and transport of nucleoside-derived drugs using electrophysiological methods Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1395 - C1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, K. M. Smith, T. Tackaberry, X. Sun, P. Carpenter, M. D. Slugoski, M. J. Robins, L. P. C. Nielsen, I. Nowak, S. A. Baldwin, et al. Characterization of the Transport Mechanism and Permeant Binding Profile of the Uridine Permease Fui1p of Saccharomyces cerevisiae J. Biol. Chem., September 22, 2006; 281(38): 28210 - 28221. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Clarke, V. L. Damaraju, J. Zhang, D. Mowles, T. Tackaberry, T. Lang, K. M. Smith, J. D. Young, B. Tomkinson, and C. E. Cass The Role of Human Nucleoside Transporters in Cellular Uptake of 4'-Thio-beta-D-arabinofuranosylcytosine and beta-D-Arabinosylcytosine Mol. Pharmacol., July 1, 2006; 70(1): 303 - 310. [Abstract] [Full Text] [PDF] |
||||